Single-dose therapeutic interfering particle lowers SARS-CoV-2 pathogenesis and shedding among hamsters

Por um escritor misterioso

Last updated 31 janeiro 2025

Single-dose therapeutic interfering particle lowers SARS-CoV-2 pathogenesis and shedding among hamsters

Researchers reported that a single-dose therapeutic interfering particle (TIP) lowers SARS-CoV-2 pathogenesis and shedding among hamsters.

Comprehensive role of SARS‐CoV‐2 spike glycoprotein in regulating host signaling pathway - Banerjee - 2022 - Journal of Medical Virology - Wiley Online Library

A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model - ScienceDirect

Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis

SARS-CoV-2 pathogenesis Nature Reviews Microbiology

Current advances in the development of SARS-CoV-2 vaccines

Frontiers Prospects of animal models and their application in studies on adaptive immunity to SARS-CoV-2

The Sleep-Immune Crosstalk in Health and Disease

Full article: Alteration of the gut microbiota following SARS-CoV-2 infection correlates with disease severity in hamsters

A single-administration therapeutic interfering particle reduces SARS-CoV-2 viral shedding and pathogenesis in hamsters

New Antiviral Therapy May Block COVID-19 Transmission

Recomendado para você